ASCO 2021: Updated results of MONALEESA-3 show sustained overall survival benefits with ribociclib in advanced breast cancer June 15, 2021
A phase I study of alpelisib + trastuzumab + LJM716 for PIK3CA-mutated HER2+ metastatic breast cancer June 14, 2021